Kemin says that the study results support Neumentix’s potential for use in the sports and nootropic markets.
Photo © iStockphoto.com/dirkr
A new, clinical study found that supplementation with Kemin Industries’ (Des Moines, IA) proprietary Neumentix Phenolic Complex K110-42 spearmint extract may help to increase reaction time, focus, and agility in young, healthy individuals. Previous clinical studies focused on Neumentix’s ability to support cognitive function, but in this human trial, researchers sought to establish Neumentix’s efficacy in enhancing key markers of physical performance, given that the link between cognitive and physical performance is a growing area of interest. The company says that the study results support Neumentix’s potential for both sports and nootropic markets.
The study group comprised healthy and active participants between the ages of 18 and 50. The study group received 900 mg of Neumentix at breakfast each day for 90 days. A second group was given an equivalent dose of a placebo and served as the control.
In the study, researchers measured participants’ cognitive and physical performance using the Makoto Arena, a 360-degree, multi-planar, game-like environment. The Makoto Arena is said to closely mimic a sports environment, and it is designed assess the link between cognitive function and physical performance. Specifically, the Makoto Arena measures reaction time to various stimuli, mental focus, hand-eye coordination, and foot-eye coordination. The researchers found that the group given Neumentix demonstrated improved reaction time after seven days, and improved focus and agility after 30 days, leading them to conclude that Neumentix may boost cognitive performance in a sports setting.
Kim Colletti, global product manager, Kemin, commented on the findings in a press release: “Neumentix stands out in the nootropic market because of its demonstrated efficacy and safety. It’s been studied in three clinical trials and has also recently earned Generally Recognized as Safe (GRAS) status. Data from this Makoto study gives supplement manufacturers the flexibility to formulate with Neumentix in a variety of growing categories, for both cognitive and athletic performance.”
The unpublished study was recently presented at the International Society of Sports Nutrition (ISSN).